Julia C. Kuehn

Freiburg, BW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Spatial immune profiling complements genomic sequencing in biliary tract cancer: hypothesis-generating use cases.

Spatial immune profiling complements genomic sequencing in biliary tract cancer: hypothesis-generating use cases.

Journal: ESMO gastrointestinal oncology

Published: April 06, 2026

Clinical Impact of Molecular Tumor Board Inclusion on Treatment Outcomes in Neuroendocrine Neoplasms.

Clinical Impact of Molecular Tumor Board Inclusion on Treatment Outcomes in Neuroendocrine Neoplasms.

Journal: Neuroendocrinology

Published: January 24, 2026

Spatial and multi-omic profiling reveals pericyte-derived CCL19 as a key prognostic factor in CNS lymphoma.

Spatial and multi-omic profiling reveals pericyte-derived CCL19 as a key prognostic factor in CNS lymphoma.

Journal: HemaSphere

Published: January 20, 2026

Molecular Tumor Boards in Malignant Melanoma: Uncovering Challenges and Opportunities in a Bicenter Retrospective Analysis in Germany.

Molecular Tumor Boards in Malignant Melanoma: Uncovering Challenges and Opportunities in a Bicenter Retrospective Analysis in Germany.

Journal: International journal of cancer

Published: December 18, 2025

Comprehensive molecular profiling of urologic tumors presented in a molecular tumor board: insights from a real-world precision oncology cohort.

Comprehensive molecular profiling of urologic tumors presented in a molecular tumor board: insights from a real-world precision oncology cohort.

Journal: Frontiers in oncology

Published: August 19, 2025

Trop-2 expression in solid tumors : Expanded protein diagnostics within the molecular tumor board

Trop-2 expression in solid tumors : Expanded protein diagnostics within the molecular tumor board

Journal: Pathologie (Heidelberg, Germany)

Published: April 30, 2025

Guiding clinical management of patients with CNS lymphomas by minimal-invasive detection of ctDNA in cerebrospinal fluid.

Guiding clinical management of patients with CNS lymphomas by minimal-invasive detection of ctDNA in cerebrospinal fluid.

Journal: Leukemia

Published: January 24, 2025

The effect of ibrutinib on the myeloid cell compartment in CNS lymphoma.

The effect of ibrutinib on the myeloid cell compartment in CNS lymphoma.

Journal: Leukemia

Published: January 24, 2025

Intraoperative classification of CNS lymphoma and glioblastoma by AI-based analysis of Stimulated Raman Histology (SRH).

Intraoperative classification of CNS lymphoma and glioblastoma by AI-based analysis of Stimulated Raman Histology (SRH).

Journal: Brain & spine

Published: September 15, 2024

Comprehensive genetic profiling and molecularly guided treatment for patients with primary CNS tumors.

Comprehensive genetic profiling and molecularly guided treatment for patients with primary CNS tumors.

Journal: NPJ precision oncology

Published: April 29, 2024

Liquid biopsy for improving diagnosis and monitoring of CNS lymphomas: A RANO review.

Liquid biopsy for improving diagnosis and monitoring of CNS lymphomas: A RANO review.

Journal: Neuro-oncology

Published: April 10, 2024

Improved early outcome prediction by MRI-based 3D tumor volume assessment in patients with CNS lymphomas.

Improved early outcome prediction by MRI-based 3D tumor volume assessment in patients with CNS lymphomas.

Journal: Neuro-oncology

Published: September 15, 2023

Showing 1-12 of 14

Last Updated: 09/26/2026